C. Activating germline variants in the RET receptor tyrosine kinase
Why this is correct
Multiple endocrine neoplasia type 2 results from activating germline pathogenic RET variants and is usually inherited in an autosomal dominant fashion. MEN2A typically includes medullary thyroid carcinoma, pheochromocytoma and sometimes parathyroid hyperplasia, whereas MEN2B features medullary thyroid cancer, pheochromocytoma, mucosal neuromas and marfanoid habitus. Medullary cancer arises from thyroid parafollicular C cells and secretes calcitonin.
Why each option is correct or incorrect
VHL pathogenic variants predispose to hemangioblastomas, clear-cell renal carcinoma and pheochromocytoma, but the classic medullary-thyroid MEN2 pattern is RET.
MEN1 loss is linked to parathyroid, pituitary and pancreatic neuroendocrine tumors rather than classic MEN2 medullary carcinoma.
Correct: activating RET variants are the hallmark of MEN2 syndromes.
TSC2-associated tuberous sclerosis is characterized by hamartomas and other lesions, not typical MEN2 clustering.
High-yield notes
- MEN2 is driven by activating RET variants.
- Medullary thyroid carcinoma originates from calcitonin-secreting C cells.
- Pheochromocytoma must be considered before thyroid surgery in MEN2.
Medullary thyroid cancer with pheochromocytoma strongly suggests MEN2/RET.
Do not confuse MEN1's '3 Ps' with MEN2's medullary thyroid carcinoma and pheochromocytoma.